<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>Provigil Clinical Review</title>
  <link>https://www.modafinilprovigill.com/</link>
  <description>Evidence-Based Insights on Cognitive Enhancement</description>
  <language>en</language>
  <lastBuildDate>Sat, 05 Sep 2026 12:24:06 GMT</lastBuildDate>
  <atom:link href="https://www.modafinilprovigill.com/feed.xml" rel="self" type="application/rss+xml"/>
  <item>
    <title>Under the Microscope: What Clinical Evidence Reveals About Modafinil Use in High-Stakes Professions</title>
    <link>https://www.modafinilprovigill.com/modafinil-off-label-use-high-stakes-professions-clinical-evidence/</link>
    <guid isPermaLink="true">https://www.modafinilprovigill.com/modafinil-off-label-use-high-stakes-professions-clinical-evidence/</guid>
    <description>From military aviators to surgical residents, modafinil&#039;s off-label use as a cognitive enhancer in high-pressure professional settings has attracted substantial scientific scrutiny. A review of the available clinical trial data, occupational research, and regulatory guidance presents a nuanced picture — one that balances genuine performance benefits against important safety, ethical, and legal considerations.</description>
    <author>Provigil Clinical Review</author>
    <category>Clinical Research &amp; Professional Use</category>
    <pubDate>Sat, 05 Sep 2026 12:20:41 GMT</pubDate>
  </item>
  <item>
    <title>Racemic vs. Enantiopure: A Clinical Comparison of Modafinil and Armodafinil for Sustained Cognitive Performance</title>
    <link>https://www.modafinilprovigill.com/modafinil-vs-armodafinil-clinical-comparison-cognitive-performance/</link>
    <guid isPermaLink="true">https://www.modafinilprovigill.com/modafinil-vs-armodafinil-clinical-comparison-cognitive-performance/</guid>
    <description>Modafinil and armodafinil share a common pharmacological lineage, yet their structural and metabolic distinctions produce meaningfully different clinical profiles. This review examines onset kinetics, duration of action, dosing considerations, and real-world tolerability to help clinicians and informed patients determine which agent may be better suited to specific cognitive demands and work schedules.</description>
    <author>Provigil Clinical Review</author>
    <category>Pharmacology &amp; Drug Comparisons</category>
    <pubDate>Sat, 05 Sep 2026 12:20:41 GMT</pubDate>
  </item>
</channel>
</rss>